logo

For the Inventor, By the Inventor

San Diego, CA, United States of America

Cylene Pharmaceuticals, Inc.


USPTO Granted Patents = 21

% Expired Patents = 61.9

Forward Citations = 178

Loading Chart...
Loading Chart...

16 inventors (with patents filed for the assignee):

goldMedal Michael Schwaebe (15 out of 19 patents)

silverMedal Jeffrey Paul Whitten (15 out of 68 patents)

bronzeMedal Fabrice Pierre (8 out of 21 patents)

4.  Adam Siddiqui-Jain (6 out of 7 patents)

5.  Johnny Yasuo Nagasawa (6 out of 27 patents)

6.  Mustapha Haddach (5 out of 34 patents)

7.  Peter C Chua (5 out of 8 patents)

8.  Terence J Moran (5 out of 12 patents)

9.  Terrance Moran (3 out of 3 patents)

10.  Collin Regan (2 out of 7 patents)

11.  Laurence H Hurley (2 out of 26 patents)

12.  Joe Anh Tran (1 out of 12 patents)

13.  Michael E Jung (1 out of 81 patents)

14.  George Yiannikouros (1 out of 16 patents)

15.  Levan Darjania (1 out of 2 patents)


21 patents:

1. 8367681 - Pyrazolopyrimidines and related heterocycles as kinase inhibitors (2013-02-05),
2. 8168651 - Protein kinase modulators (2012-05-01),
3. 8124649 - Oxindole compounds (2012-02-28),
4. 7956064 - Fused tricyclic compounds as serine-threonine protein kinase and PARP modulators (2011-06-07),
5. 7928100 - Quinolone analogs and methods related thereto (2011-04-19),
6. 7910600 - Therapeutic kinase modulators (2011-03-22),
7. 7834180 - Methods of preparing quinolone analogs (2010-11-16),
8. 7816524 - Methods of preparing quinolone analogs (2010-10-19),
9. 7816406 - Quinolone analogs (2010-10-19),
10. 7652134 - Methods for converting quinolone esters into quinolone amides (2010-01-26),
11. 7612063 - Substituted quinobenzoxazine analogs (2009-11-03),
12. 7507727 - Substituted quinobenzoxazine analogs and methods of using thereof (2009-03-24),
13. 7402579 - Quinobenzoxazine analogs and compositions (2008-07-22),
14. 7381720 - Substituted quinobenzoxazine analogs (2008-06-03),
15. 7354916 - Substituted quinobenzoxazine analogs (2008-04-08),
Company Overview
Cylene Pharmaceuticals, Inc. is a biotechnology company based in San Diego, California, focused on developing innovative therapies for cancer and other serious diseases. The company specializes in the discovery and advancement of small molecule drugs that target specific cellular pathways, aiming to improve treatment outcomes for patients. Cylene's research emphasizes precision medicine and the development of novel compounds that address unmet medical needs, leveraging cutting-edge technologies in drug discovery and development.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

21 Patents

#289 in San Diego, CA

#3,760 in California

#15,695 in US

#29,961 in the World

San Diego, CA (US)
San Diego, CA, United States of America

Cylene Pharmaceuticals, Inc.

Forward Citations = 178

16 inventors:

goldMedal Michael Schwaebe (15 out of 19 patents)

silverMedal Jeffrey Paul Whitten (15 out of 68 patents)

bronzeMedal Fabrice Pierre (8 out of 21 patents)

4.  Adam Siddiqui-Jain (6 out of 7 patents)

5.  Johnny Yasuo Nagasawa (6 out of 27 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Cylene Pharmaceuticals, Inc.. Retrieved from https://idiyas.com/company/cylene-pharmaceuticals

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…